Endovascular
Techniques and Lesion Subsets Learning Series
Pulmonary Hypertension and Embolism Therapies
Episodes
PEERLESS Trial: Editorial Commentary
9 min.
Large-bore Mechanical Thrombectomy vs Catheter-directed Thrombolysis for Treatment of Intermediate-Risk Pulmonary Embolism: Primary Outcomes From the PEERLESS Randomized Controlled Trial
10 min.
TCT 1473: More Than Meets the Lung: Shocking Etiology of Saddle Pulmonary Embolism
11 min.
TCT 1391: Averting Catastrophe: A Case of and the Case for a Door-to-Embolectomy Paradigm in Catastrophic Pulmonary Embolism
14 min.
TCT 1375: Right Ventricular Dysfunction: Navigating the Aftermath of Massive Pulmonary Embolism
15 min.
TCT 1095: Graded Coronary Non Compliant Balloon Atrial Septostomy Technique Rescue Severe Refractory Pulmonary Hypertension in Patient With Antiphospholipid Syndrome and Recurrent Pulmonary Emboli, Along With Chronic Thromboembolic Pulmonary Hypertension Following Pulmonary Endarterectomy
6 min.
Where Does Interventional Cardiologist Fit in Advancing Interventional Treatment of Pulmonary Thromboembolism?
9 min.
Case 2: Neurosurgical Patient With High Risk Intermediate PE
27 min.
Case 1: Massive PE With Shock
30 min.
Case 3: High Risk Intermediate PE With Iliocaval DVT
33 min.
tate of the Art Lecture: PE New Devices and Catheters: What Will Be New in 2024?
13 min.
Catheter Interventions for Pulmonary Embolism: Clinical Trial Update
10 min.
Modeling the RV Through HARVI
20 min.
Advances in RV Assessment Through TTE
10 min.
New Risk Stratification Tools: AI, Biomarkers, Invasive Hemodynamics, etc.
10 min.
What Skills Are Needed to Start a Balloon Pulmonary Angioplasty Program?
9 min.
Complications With Catheter Therapy
17 min.
How to Establish an Effective Post-PE Pathway
8 min.
Institutional Multidisciplinary Approach to Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
13 min.
Invasive Hemodynamic Assessment in the Pulmonary Embolism
11 min.
Catheter Thrombectomy 101: Tips, Tricks, and Pitfalls, Small Bore and Large Bore
8 min.
Catheter-Directed Thrombolysis: Protocols, Duration, etc
8 min.
Why Should a Cardiologist Care About Pulmonary Embolism?
9 min.
Debate: Intermediate-Risk Pulmonary Embolism — No Data for Catheters, Stick With Heparin!
8 min.
Debate: Intermediate-Risk Pulmonary Embolism – Catheter Thrombectomy Is Best
7 min.
Debate: Intermediate-Risk Pulmonary Embolism – Catheter-directed Thrombolysis as the Primary Option
9 min.
Debate: High-risk Pulmonary Embolism – Surgery Is the Way
14 min.
Debate: High-risk Pulmonary Embolism – Catheter Therapy First in the Modern Era
8 min.
Debate: High-risk Pulmonary Embolism – Systemic Thrombolysis Is Still the Gold Standard
8 min.
PE Risk Stratification in 2023
11 min.
Keynote Lecture: Advances in Interventional Treatment of Pulmonary and Right Heart Thrombosis
14 min.
Intelligent Interventions: Personalized Medicine for VTEs (FlowMedical)
11 min.
PFO PRIMER: Updates and Spotlights – Technology and Techniques: Difficult Cases
6 min.
Real World Experience of Contemporary Pulmonary Embolism Treatment (USCDT versus MT): Insights From Big Data Analytics (REAL-PE)
18 min.
BPA in CTEPH Management
10 min.
Pulmonary Artery Denervation: Innovative Pulmonary Hypertension Therapies
9 min.
Catheter-Based Management of Infectious Endocarditis
8 min.
CTEPH? CTED? How Do We Make the Diagnosis?
9 min.
Anticoagulation for PE: When to Switch to DOACs?
6 min.
Getting Smart With PE Diagnosis: The Role of AI
8 min.
The PERT Effect: How to Establish a Multdisciplinary Care Team for PE
8 min.
State-of-the-Art Lecture: Future Device Therapies in PE
12 min.
What Do the Clinical Trials Tell Us to Do in Intermediate-Risk PE?
10 min.
Large Bore Thrombectomy: Are We Any Closer to Understanding Which Device Is Best?
10 min.
Catheter Directed Thrombolysis: New Devices, Drugs, and Duration?
10 min.
Intermediate-Risk PE Case (NewYork-Presbyterian/Columbia University Irving Medical Center): Case Intro
2 min.
Massive PE Case (NewYork-Presbyterian/Columbia University Irving Medical Center): Case Conclusion
3 min.
TCT 694: Debulking Tricuspid Valve Vegetations: Using AngioVac to Avoid Reoperations for Prosthetic Valve Endocarditis
6 min.
Iliocaval Stenting and Reconstructions With Extreme Case Examples
12 min.
R Sided Clot in Transit
9 min.
BPA for CTEPH: When and How?
10 min.
Anticoagulation Strategies in High-Risk PE: Are DOACs Enough? When Do We Switch?
8 min.
Is There a Role for MCS in Massive PE and Which Modality?
8 min.
Surgical Embolectomy Is the Way to Go in High-Risk PE
7 min.
Who Gets Systemic Thrombolysis Anymore?
9 min.
High-Risk PE Case (NewYork-Presbyterian/Columbia University Irving Medical Center): Case Introduction
2 min.
Aspiration Thrombectomy: a Potential Treatment for Pulmonary Embolism in COVID-19
5 min.
The immediate change in cardiac and hemodynamic physiology following catheter-directed alleviation of intermediate high-risk pulmonary embolism
5 min.
FlowTriever Thrombectomy for “Intermediate Risk” Pulmonary Embolism in a Jehovah’s Witness Patient
5 min.
Case : Emergent thrombectomy in PE with shock
5 min.
Innovation in Interventional PE Therapies
9 min.
Case 2: COVID Patient With Clot in Transit
7 min.
Case 1: Catastrophic PE With Shock
7 min.
Catheter-Based Thrombus Extraction Using Electro-Magnetic Fields (Magneto eTrieve™)
7 min.